Our data demonstrated that from the immunophenotypic standing point, the analysis of tumor infiltrating CD4+ and CD8+ T-cells may represent important complementary prognosis biomarkers to be further investigated in canine mammary carcinomas. This evidence concerns the gene CD8A and neoplasm.